MedDataX Logo

Insulin Sensitivity and Substrate Metabolism in Patients With Cushing's Syndrome

NCT ID: NCT00682084

Last Updated: 2017-12-22

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Total Enrollment

1 participants

Study Classification

OBSERVATIONAL

Study Start Date

2008-04-30

Study Completion Date

2016-11-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to investigate the effect og chronic elevated levels of cortisol on metabolism and insulin sensitivity.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cushing's Syndrome Insulin Resistance

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

Cushing's syndrome Glucose tolerance Insulin sensitivity Substrate metabolism Body composition

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

Patients recently diagnosed with Cushing's syndrome

Surgery

Intervention Type PROCEDURE

Surgical removal of either a pituitary or ectopic ACTH producing tumor or an adrenal tumor

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Surgery

Surgical removal of either a pituitary or ectopic ACTH producing tumor or an adrenal tumor

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Written consent
* Age between 18 and 70
* Diagnosed with Cushing's syndrome

Exclusion Criteria

* Suspected malignancy
Minimum Eligible Age

18 Years

Maximum Eligible Age

70 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Aarhus University Hospital

OTHER

Sponsor Role collaborator

University of Aarhus

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jens Otto L. Jørgensen, Professor MD

Role: PRINCIPAL_INVESTIGATOR

Aarhus University Hospital, Department of Endocrinology

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Department of Endocrinology

Aarhus C, Aarhus, Denmark

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Denmark

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

MM-ISC-20070131

Identifier Type: -

Identifier Source: org_study_id